Busulfan–melphalan in High-Risk Neuroblastoma: The 30-Year Experience of a Single Institution
Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2016.75
Full Text
Open PDFAbstract
Available in full text
Date
April 4, 2016
Authors
Publisher
Springer Science and Business Media LLC